IND filing of tivoxavir marboxil represents final step for formal consideration by the Center for the Biomedical Advanced ...
Silo Pharma Files Patent Application for Alzheimer's Drug SPC-14 Targeting Novel Mechanism of Action
Silo Pharma, Inc. has announced the filing of a patent application for its neurology drug, SPC-14, which is an intranasal treatment for Alzheimer's disease. This compound, licensed from Columbia ...
Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through three ...
LONDON and NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (OKYO) (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of ...
Ascelia Pharma AB ( (SE:ACE)) just unveiled an announcement. Ascelia Pharma has filed a new patent application for Orviglance, an innovative liver imaging drug designed to enhance the detection of ...
IND filing of tivoxavir marboxil represents final step for formal consideration by the Center for the Biomedical Advanced ...
MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the filing of its 2024 Universal Registration ...
Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback